v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Research and development $ 4,544 $ 13,666
General and administrative 6,624 10,920
Total operating expenses 11,168 24,586
Operating loss (11,168) (24,586)
Interest income 789 1,265
Other income (loss), net 48 (82)
Net loss $ (10,331) $ (23,403)
Net loss per share, basic and diluted (in dollars per share) $ (0.21) $ (0.48)